Literature DB >> 12269831

Substrate-based design of reversible Pin1 inhibitors.

Yixin Zhang1, Susanne Füssel, Ulf Reimer, Mike Schutkowski, Gunter Fischer.   

Abstract

Human Pin1, a peptidyl-prolyl cis/trans isomerase with high specificity to -Ser/Thr(PO(3)H(2))-Pro- motifs, is required for cell cycle progression. In an effort to design reversible Pin1 inhibitors by using a substrate structure based approach, a panel of peptides were applied to systematically analyze the minimal structural requirements for Pin1 substrate recognition. Pin1 catalysis (k(cat)/K(m) < 5 mM(-1) s(-1)) for Ala-Pro, Ser-Pro, and Ser(PO(3)H(2))-Pro was detected using direct UV-visible spectrophotometric detection of prolyl isomerization, while weak competitive inhibition of Pin1 by these dipeptides was observed (K(i) > 1 mM). Substrates with chain lengths extending from either the P2 to P1' or the P1 to P2' subsite gave k(cat)/K(m) values of 100 mM(-1) s(-1) for Ala-Ser(PO(3)H(2))-Pro and 38 mM(-1) s(-1) for Ser(PO(3)H(2))-Pro-Arg. For both Pin1 and its yeast homologue Ess1, the optimal subsite recognition elements comprise five amino acid residues with the essential Ser(PO(3)H(2)) in the middle position. The resulting substrate Ac-Ala-Ala-Ser(PO(3)H(2))-Pro-Arg-NH-4-nitroanilide possesses a very low cis/trans interconversion barrier in the presence of either Pin1 or Ess1, with k(cat)/K(m) = 9300 mM(-1) s(-1) and 12000 mM(-1) s(-1), respectively. The D-Ser(PO(3)H(2)) residue preceding proline could serve as a substrate-deactivating determinant without compromising ground state affinity. Similarly, substitution of the amide bond preceding proline with a thioxo amide bond produces a potent inhibitor. Pin1 is reversibly inhibited by such substrate analogue inhibitors with IC(50) values in the low micromolar range. The D-amino acid containing inhibitor also exhibits remarkable stability against phosphatase activity in cell lysate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12269831     DOI: 10.1021/bi0262395

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Multiple roles for the Ess1 prolyl isomerase in the RNA polymerase II transcription cycle.

Authors:  Zhuo Ma; David Atencio; Cassandra Barnes; Holland DeFiglio; Steven D Hanes
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

2.  Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.

Authors:  Man-Li Luo; Chang Gong; Chun-Hau Chen; Daniel Y Lee; Hai Hu; Pengyu Huang; Yandan Yao; Wenjun Guo; Ferenc Reinhardt; Gerburg Wulf; Judy Lieberman; Xiao Zhen Zhou; Erwei Song; Kun Ping Lu
Journal:  Cancer Res       Date:  2014-05-01       Impact factor: 12.701

3.  The structure of the Candida albicans Ess1 prolyl isomerase reveals a well-ordered linker that restricts domain mobility.

Authors:  Zhong Li; Hongmin Li; Gina Devasahayam; Trent Gemmill; Vishnu Chaturvedi; Steven D Hanes; Patrick Van Roey
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

Review 4.  Prolyl isomerases in gene transcription.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-10-31

5.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.

Authors:  Tao Liu; Yu Liu; Hung-Ying Kao; Dehua Pei
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

6.  Structure and dynamics of pin1 during catalysis by NMR.

Authors:  Wladimir Labeikovsky; Elan Z Eisenmesser; Daryl A Bosco; Dorothee Kern
Journal:  J Mol Biol       Date:  2007-01-24       Impact factor: 5.469

7.  Discovery and binding studies on a series of novel Pin1 ligands.

Authors:  Bainan Wu; Michele F Rega; Jun Wei; Hongbin Yuan; Russell Dahl; Ziming Zhang; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2009-04       Impact factor: 2.817

8.  The Ess1 prolyl isomerase is required for transcription termination of small noncoding RNAs via the Nrd1 pathway.

Authors:  Navjot Singh; Zhuo Ma; Trent Gemmill; Xiaoyun Wu; Holland Defiglio; Anne Rossettini; Christina Rabeler; Olivia Beane; Randall H Morse; Michael J Palumbo; Steven D Hanes
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

Review 9.  The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-02-12

10.  Structural basis for high-affinity peptide inhibition of human Pin1.

Authors:  Yan Zhang; Sebastian Daum; Dirk Wildemann; Xiao Zhen Zhou; Mark A Verdecia; Marianne E Bowman; Christian Lücke; Tony Hunter; Kun-Ping Lu; Gunter Fischer; Joseph P Noel
Journal:  ACS Chem Biol       Date:  2007-05-22       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.